Logotype for Apollo Hospitals Enterprise Limited

Apollo Hospitals (APOLLOHOSP) Q2 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Apollo Hospitals Enterprise Limited

Q2 2026 earnings summary

9 Jul, 2026

Executive summary

  • Q2 FY26 consolidated revenue grew 13% year-over-year to INR 6,304 crore (₹63,035 million), with EBITDA up 15% and PAT up 26%.

  • All core divisions—Healthcare Services, Apollo HealthCo/Digital Health & Pharmacy Distribution, and AHLL/Diagnostics & Retail Health—delivered double-digit revenue growth despite seasonal impacts.

  • H1 FY26 consolidated revenue was INR 12,146 crore (₹121,456 million), up 14% year-over-year, with EBITDA up 20% and PAT up 33%.

  • Expansion projects include commissioning six new hospitals by end of next fiscal and adding 4,400 capacity beds (~3,600 census beds) over five years.

  • Clinical milestones include over 51 lakh surgeries, 27,000 organ transplants, and pioneering robotic telesurgery.

Financial highlights

  • Q2 FY26 consolidated revenue: INR 6,304 crore (₹63,035 million, +13% YoY); EBITDA: INR 941 crore (₹9,412 million, +15% YoY); PAT: INR 477 crore (₹4,772 million, +26% YoY).

  • H1 FY26 consolidated revenue: INR 12,146 crore (₹121,456 million, +14% YoY); EBITDA: INR 1,793 crore (₹17,931 million, +20% YoY); PAT: INR 910 crore (₹9,100 million, +33% YoY).

  • Healthcare Services Q2 revenue: INR 3,169 crore (₹31,690 million, +9% YoY); EBITDA margin: 24.6%.

  • Apollo HealthCo/Digital Health & Pharmacy Distribution Q2 revenue: INR 2,661 crore (₹26,606 million, +17% YoY); EBITDA: INR 110 crore; GMV at INR 723 crore (+16% YoY); 44 million users.

  • AHLL/Diagnostics & Retail Health Q2 revenue: INR 474 crore (₹4,739 million, +17% YoY); EBITDA: INR 50 crore (21% YoY); margin at 10.6%.

Outlook and guidance

  • Organic growth in healthcare services expected to return to 13% in existing beds, with an additional 5% from new beds over the next two years.

  • Six new hospitals to be fully operational by end of next fiscal, with ramp-up plans staggered across Q3, Q4, and Q1.

  • Targeting annualized revenue run rate of ₹250 billion by Q4FY27 with 7% EBITDA margin.

  • Digital business cost structure has stabilized, with further synergies expected post-integration.

  • Management plans to deepen technology partnerships and expand AI capabilities.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more